Protective effects of thromboxane synthetase inhibitors in rats in endotoxic shock.
D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D005338:Fibrin Fibrinogen Degradation Products; D007093:Imidazoles / Q000627:therapeutic use; D008247:Lysosomes / Q000201:enzymology; D008297:Male; D010088:Oxidoreductases / Q000494:pharmacology*; D011458:Prostaglandins E / Q000097:blood; D051381:Rats; D012772:Shock, Septic / Q000209:etiology*; D013921:Thrombocytopenia / Q000188:drug therapy; D013929:Thromboxane B2 / Q000097:blood; D013930:Thromboxane-A Synthase / Q000494:pharmacology*
D005338:Fibrin Fibrinogen Degradation Products; D007093:Imidazoles; D011458:Prostaglandins E; D013929:Thromboxane B2; C024335:1-(7-carboxyhexyl)imidazole; D010088:Oxidoreductases; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D013930:Thromboxane-A Synthase